Compare PODD & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PODD | JLL |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United States |
| Employees | N/A | 48000 |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 16.8B |
| IPO Year | 2007 | 1997 |
| Metric | PODD | JLL |
|---|---|---|
| Price | $196.31 | $317.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 7 |
| Target Price | $349.80 | ★ $363.17 |
| AVG Volume (30 Days) | ★ 874.8K | 424.6K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.13 |
| EPS | 3.48 | ★ 16.40 |
| Revenue | $2,708,100,000.00 | ★ $26,115,600,000.00 |
| Revenue This Year | $24.59 | $7.70 |
| Revenue Next Year | $19.18 | $6.91 |
| P/E Ratio | $57.22 | ★ $19.54 |
| Revenue Growth | ★ 30.73 | 11.45 |
| 52 Week Low | $197.54 | $201.97 |
| 52 Week High | $354.88 | $363.06 |
| Indicator | PODD | JLL |
|---|---|---|
| Relative Strength Index (RSI) | 22.91 | 59.45 |
| Support Level | N/A | $316.43 |
| Resistance Level | $299.75 | $322.89 |
| Average True Range (ATR) | 6.96 | 8.62 |
| MACD | -0.67 | 3.12 |
| Stochastic Oscillator | 4.49 | 78.16 |
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.